港股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

抗疫概念

922.671

+26.1432.92%

漲家數：11

跌家數：5

平家數：2

市盈率：- -

高：932.797

開：893.740

低：891.998

收：896.528

資料載入中...

總覽新聞資訊

健康險公司淨利潤顯著增長，行業整體表現亮眼

海獅07 DM-i上市比亞迪全新SUV挑戰中大型插混市場新標杆

中国经营报

阿里內部“通網拆牆”：調整轉崗機制，吳泳銘喊話要重新創業

比亞迪、青山控股取消智利鋰電工廠計劃！

锂电新材料

比亞迪申請換熱板、電池包和用電裝置專利，增強電池換熱效果

比亞迪合肥號、開拓者1號相繼抵達巴西，合計裝載超萬輛新能源車

比亞迪和青山重申在智利建廠的意向此前智利稱項目已取消

廣東天普生化醫藥股份有限公司申請III類會議

券商聚焦醫藥領域持倉、調研多管齊下覓先機

中國駐智利大使館：比亞迪和青山未公司停止投資願與當地政府對話

石藥集團1類新藥SYH2046獲FDA批准開展臨牀試驗

復星醫藥(02196)附屬菌濟健康獲美國 FDA 藥品臨牀試驗批准

阿里吳泳銘再提創業，將採用“飽和式投入”打法

石藥集團(01093)：SYH2046片獲美國臨牀試驗批准

石藥集團：SYH2046片獲美國臨牀試驗批准

即時零售大戰前傳：互聯網健康的十年“三國殺”

华尔街见闻

石藥集團(01093)5月9日註銷2545萬股已回購股份

爭奪水光針200億市場華熙生物接連獲批2款合規產品四環醫藥、樂普醫療加入混戰

“太平洋醫藥”君實生物公司點評：拓益收入同比增長 46%，關注 DKK1 胃腸道腫瘤早期數據

復星醫藥子公司獲美國FDA批准開展AGA治療臨牀試驗

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BK1515/news?page=3"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1515","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","market":"HK","secType":"PLATE","nameCN":"抗疫概念","latestPrice":922.6707,"timestamp":1747037290222,"preClose":896.528,"halted":0,"volume":639468156,"delay":0,"changeRate":0.02916,"floatShares":0,"shares":0,"eps":0,"marketStatus":"已收盤","change":26.1427,"latestTime":"05-12 16:00:00","open":893.73975,"high":932.79736,"low":891.99774,"amount":5930868565.5,"amplitude":0.045508,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1747099800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1747013400000,1747022400000],[1747026000000,1747036800000]],"pbRate":1.585523,"peRate":21.198848,"turnoverRate":0.008452,"increases":11,"decrements":6,"flats":1,"marketCap":634840009216,"floatMarketCap":524045002368},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","high":932.79736,"amplitude":0.045508,"preClose":896.528,"low":891.99774,"pbRate":"1.585523","latestPrice":922.6707,"volume":639468156,"delay":0,"open":893.73975,"prevYearClose":787.97723,"prevWeekClose":896.528,"prevMonthClose":903.998,"prevQuarterClose":870.015,"fiveDayClose":921.416,"twentyDayClose":756.168,"sixtyDayClose":879.539,"secType":"PLATE","market":"HK","turnoverRate":0.008452,"peRate":21.198848,"marketCap":634840009216,"floatMarketCap":524045002368,"timestamp":1747037290222,"nameCN":"抗疫概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1515\",,,,undefined,":{"bkCode":"BK1515","up":11,"down":5,"flat":2},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1515\",pageSize:20,pageCount:3,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2534477484","title":"健康險公司淨利潤顯著增長，行業整體表現亮眼","url":"https://stock-news.laohu8.com/highlight/detail?id=2534477484","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534477484?lang=zh_tw&edition=fundamental","pubTime":"2025-05-11 10:03","pubTimestamp":1746929024,"startTime":"0","endTime":"0","summary":"根据已披露的数据，人保健康、平安健康保险、太保健康险、复星联合健康和瑞华保险等五家公司在2024年合计实现营业收入756.46亿元，同比增长14.1%；净利润达到41.51亿元，同比增长46.6%。其中，人保健康保费规模位居第一，2024年实现保险业务收入486.95亿元，净利润19.32亿元，同比增长29.6%。平安健康保险去年净利润跃居首位，实现保险服务收入165.25亿元，净利润19.98亿元，同比大增39.1%。健康险公司净利润的增长主要得益于负债端收入的稳健增长以及投资端的良好表现。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/05/11100350293203.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1571","BK1615","BK1515","01833","BK1219","BK1247","BK1617","BK1142"],"gpt_icon":0},{"id":"2534544476","title":"海獅07 DM-i上市 比亞迪全新SUV挑戰中大型插混市場新標杆","url":"https://stock-news.laohu8.com/highlight/detail?id=2534544476","media":"中国经营报","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534544476?lang=zh_tw&edition=fundamental","pubTime":"2025-05-11 06:26","pubTimestamp":1746915975,"startTime":"0","endTime":"0","summary":"5月8日，比亚迪股份有限公司（以下简称“比亚迪”）海洋网旗下全新车型——海狮07DM-i正式上市，官方指导价区间为16.98万元至20.58万元。《中国经营报》记者现场了解到，作为一款定位于中大型SUV的新品，海狮07DM-i基于比亚迪最新一代插电式混合动力整车平台打造，全面搭载第五代DM技术，展现出在动力性能与能耗控制上的综合优势。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202505113401271965.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1813983027.USD","LU0572944931.SGD","LU2097828805.USD","LU0823426480.USD","SG9999006514.SGD","002594","BK1515","LU0348825331.USD","LU0269904917.USD","01211","BYDDY","LU0823038988.USD","LU0175139822.USD","LU0828238088.HKD","LU0052750758.USD","LU0463099449.HKD","LU0509642566.USD","LU2294711713.HKD","81211","LU1770034418.SGD","LU2348774022.SGD","LU2476274720.SGD","LU0143863784.USD","LU0320764599.SGD","BK1119","LU0650527681.SGD","BK1504","LU1720050803.USD","HYDD.SI","LU0039217434.USD","SG9999015945.SGD","LU1328277881.USD","LU0979878070.USD","LU1880383440.USD","LU0605514214.HKD","00285","LU0588545490.SGD","SG9999015978.USD","LU0819123356.HKD","LU0314109678.HKD","LU0289739343.SGD","LU0054450605.USD","LU2249611893.SGD","SG9999001226.SGD","LU0823414551.USD","SG9999002463.SGD","DM","SG9999002828.SGD","LU1808992512.USD","LU0043850808.USD"],"gpt_icon":1},{"id":"2534408744","title":"阿里內部“通網拆牆”：調整轉崗機制，吳泳銘喊話要重新創業","url":"https://stock-news.laohu8.com/highlight/detail?id=2534408744","media":"时代周报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534408744?lang=zh_tw&edition=fundamental","pubTime":"2025-05-10 21:09","pubTimestamp":1746882559,"startTime":"0","endTime":"0","summary":"一年一度的“510阿里日”，阿里巴巴(09988.HK)再次释放出重磅信号。5月9日晚，杭州阿里巴巴全球总部，创始人马云意外现身，并参加了2025阿里巴巴十年馨专场音乐会。现场照片中，马云笑着挥手致意，现场随即传出掌声与欢呼声。当天下午，马云走访“湖畔小屋”。这座1:1复刻、代表阿里创业起点的“湖畔小屋”，刚刚正式亮相全球总部园区。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202505103401255480.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4505","BK1515","LU0880133367.SGD","LU1152091168.USD","LU0651947912.USD","LU1046421795.USD","BK4548","BK4535","BK4543","BK4587","09988","BK4607","LU1235294995.USD","00241","BK4524","LU0328353924.USD","LU1282648689.USD","LU0072913022.USD","BK1615","BK4533","BABA","BK4531","BK4534","LU0348814723.USD","BK1584","LU0072462343.USD","LU0310800965.SGD","LU1051768304.USD","LU0979878070.USD","LU1823568750.SGD","BK1189","LU2226246903.HKD","IE00B0JY6N72.USD","BK1247","LU1008478684.HKD","BK1610","LU0052756011.USD","LU1515016050.SGD","BK4579","LU1242518857.USD","LU0251143458.SGD","BK1617","LU1051769294.HKD","ALBmain","LU1048596156.SGD","BK1501","LU1152091754.HKD","BK1571","BK4565","LU0348816934.USD"],"gpt_icon":1},{"id":"2534422487","title":"比亞迪、青山控股取消智利鋰電工廠計劃！","url":"https://stock-news.laohu8.com/highlight/detail?id=2534422487","media":"锂电新材料","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534422487?lang=zh_tw&edition=fundamental","pubTime":"2025-05-10 20:05","pubTimestamp":1746878732,"startTime":"0","endTime":"0","summary":"当地时间5月7日，据智利《金融日报》 报道，中国汽车制造商比亚迪和金属集团青山控股均已通知智利当局，将撤回其在智利建设锂加工厂的计划。比亚迪和青山本来可以在2030年之前以优惠价格获得智利矿商SQM生产的锂。智利方面要求外企竞拍配额并捆绑建厂条件，导致谈判陷入僵局。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250511022645a479786c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250511022645a479786c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["002594","LU0164865239.USD","LU1880383366.USD","BK1582","BK1607","BK1509","SG9999014674.SGD","BK1119","LU0531971595.HKD","LU0511384066.AUD","LU2360107325.USD","LU0605514214.HKD","LU1868837722.USD","LU0214875030.USD","LU0229945570.USD","BK1149","LU0143863198.USD","LU0348825331.USD","LU1861214812.USD","LU0052750758.USD","HYDD.SI","LU0314109678.HKD","BK1504","LU0315178854.USD","LU0417516738.SGD","LU0979878070.USD","LU0594300419.USD","LU0823038988.USD","LU2153592121.USD","SG9999006597.SGD","SG9999015952.SGD","LU0348827113.USD","SG9999015978.USD","LU0463099449.HKD","LU0819121731.USD","SG9999015945.SGD","LU0326950275.SGD","LU1023057109.AUD","BK1515","BYDDY","LU0449515922.USD","LU1242518857.USD","LU1813983027.USD","LU1868837565.USD","81211","LU0348767384.USD","00285","LU0823414478.USD","01211","LU0543330566.HKD"],"gpt_icon":0},{"id":"2534744888","title":"比亞迪申請換熱板、電池包和用電裝置專利，增強電池換熱效果","url":"https://stock-news.laohu8.com/highlight/detail?id=2534744888","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534744888?lang=zh_tw&edition=fundamental","pubTime":"2025-05-10 16:12","pubTimestamp":1746864735,"startTime":"0","endTime":"0","summary":"金融界 2025 年 5 月 10 日消息，国家知识产权局信息显示，比亚迪股份有限公司申请一项名为“换热板、电池包和用电装置”的专利，公开号 CN119944164A，申请日期为 2025 年 4 月。天眼查资料显示，比亚迪股份有限公司，成立于1995年，位于深圳市，是一家以从事电气机械和器材制造业为主的企业。通过天眼查大数据分析，比亚迪股份有限公司共对外投资了98家企业，参与招投标项目969次，财产线索方面有商标信息1774条，专利信息5000条，此外企业还拥有行政许可135个。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/05/10161250289170.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0196","SG9999015952.SGD","LU1023057109.AUD","LU0819123356.HKD","81211","LU1794554557.SGD","LU0588545730.USD","LU1781817850.SGD","BK1515","LU0164872284.USD","LU0572944931.SGD","LU1242518857.USD","00285","159796","LU0315178854.USD","IE00BD6J9T35.USD","LU2148510915.USD","LU0165289439.USD","LU0633140727.USD","LU1868837565.USD","HYDD.SI","LU2097828805.USD","LU0229945570.USD","BK1594","BK1610","LU0449515922.USD","BYDDY","LU0543330566.HKD","LU0823414551.USD","LU1813983027.USD","LU1997244956.HKD","LU2153592121.USD","LU2039709279.SGD","BK0183","BK1582","EVS.SI","LU0516422366.SGD","002594","BK1589","BK0070","LU0348805143.USD","LU1188198961.HKD","LU1580142542.USD","01211","LU0871576103.HKD","LU2097828714.EUR","LU0348827113.USD","LU0143863784.USD","BK1504","LU1303224171.USD"],"gpt_icon":1},{"id":"2534415772","title":"比亞迪合肥號、開拓者1號相繼抵達巴西，合計裝載超萬輛新能源車","url":"https://stock-news.laohu8.com/highlight/detail?id=2534415772","media":"IT之家","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534415772?lang=zh_tw&edition=fundamental","pubTime":"2025-05-10 12:30","pubTimestamp":1746851410,"startTime":"0","endTime":"0","summary":"IT之家 5 月 10 日消息，“合肥号”“开拓者 1 号”是比亚迪定制的专用汽车滚装运输船，最大 7000 个标准车位，前者于 2025 年 1 月 7 日正式启航，后者已执行多次运输任务。博主 @小迪快报 今日透露，两船已于近日相继抵达巴西波图塞尔港，合计运载超 10000 辆比亚迪新能源汽车。截至 2025 年 4 月，比亚迪新能源汽车已进入全球 110 多个国家及地区。2024 年，比亚迪乘用车海外市场销售 41.7 万辆，同比增长 72%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250510124801a478ee2d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250510124801a478ee2d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0348735423.USD","LU0348825331.USD","LU0214875030.USD","BK1119","BK1540","LU0164872284.USD","BK1515","LU1242518931.SGD","HYDD.SI","LU0516422440.USD","LU0143863198.USD","81211","LU1242518857.USD","LU1868838027.USD","LU1880383440.USD","LU0274383008.USD","LU0211977185.USD","SG9999015952.SGD","LU0871576103.HKD","LU0531971595.HKD","LU0823426308.USD","LU0856984785.SGD","LU0588546209.SGD","LU0509642566.USD","SG9999001226.SGD","LU0259732245.USD","LU0229945570.USD","LU0516422952.EUR","LU0348805143.USD","LU1303224171.USD","BYDDY","LU0588545730.USD","LU0823414478.USD","SG9999002828.SGD","LU0505663152.USD","002594","LU0269904917.USD","LU1251922891.USD","SG9999014674.SGD","00285","LU2097828714.EUR","LU2294711713.HKD","LU0516423091.SGD","LU0417516738.SGD","01211","LU0359202008.SGD","BK1522","SG9999015986.USD","LU0561508036.HKD","LU1961090484.USD"],"gpt_icon":1},{"id":"2534283418","title":"比亞迪和青山重申在智利建廠的意向 此前智利稱項目已取消","url":"https://stock-news.laohu8.com/highlight/detail?id=2534283418","media":"商业周刊","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534283418?lang=zh_tw&edition=fundamental","pubTime":"2025-05-10 10:04","pubTimestamp":1746842640,"startTime":"0","endTime":"0","summary":"比亚迪和青山控股重申在智利建设锂加工厂的意向，这似乎与智利政府关于项目已被取消的说法形成反差。此前，智利当地报纸Diario Financiero报道称，比亚迪与青山已决定不再推进把碳酸锂加工为电池正极材料的项目。就比亚迪而言，这家电动汽车巨头未能与智利当局就项目条款达成协议。负责管理智利锂资源的政府机构Corfo5月7日声明称，比亚迪已于今年1月撤回了工厂选址。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-05-10/doc-inevzyrc7759163.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1522","002594","BK0188","LU2148510915.USD","LU0588546209.SGD","LU0254981946.USD","81211","BK0183","LU0561508036.HKD","BK1515","LU1997245177.USD","LU0359202008.SGD","LU2097828714.EUR","LU0314109678.HKD","HYDD.SI","BYDDY","LU2289578879.USD","LU2506951792.HKD","LU1719994722.HKD","00285","BK1607","LU0823414551.USD","BK1504","LU0516422440.USD","EVS.SI","LU0175139822.USD","LU1251922891.USD","01211","LU0588545490.SGD","LU1880383440.USD","LU2399975544.HKD","BK1594","LU2580892862.HKD","BK1580","BK1119","BK0264","LU1303224171.USD","LU0856984785.SGD","LU0164865239.USD","LU0320764599.SGD","BK0072","LU0708995583.HKD","LU1188198961.HKD","LU0540923850.HKD","LU0634319403.HKD","LU0823426308.USD","IE00BD6J9T35.USD","LU1868837565.USD","BK0014","LU2294711713.HKD"],"gpt_icon":1},{"id":"2534462146","title":"廣東天普生化醫藥股份有限公司申請III類會議","url":"https://stock-news.laohu8.com/highlight/detail?id=2534462146","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534462146?lang=zh_tw&edition=fundamental","pubTime":"2025-05-10 07:22","pubTimestamp":1746832978,"startTime":"0","endTime":"0","summary":"广东天普生化医药股份有限公司，成立于1993年，位于广州市，是一家以从事医药制造业为主的企业。通过天眼查大数据分析，广东天普生化医药股份有限公司共对外投资了4家企业，参与招投标项目758次，知识产权方面有商标信息34条，专利信息102条，此外企业还拥有行政许可119个。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/05/10072250281720.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1515","BK4134","09939","159938","III","BK1161","BK1574"],"gpt_icon":0},{"id":"2534458269","title":"券商聚焦醫藥領域 持倉、調研多管齊下覓先機","url":"https://stock-news.laohu8.com/highlight/detail?id=2534458269","media":"证券日报 ","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534458269?lang=zh_tw&edition=fundamental","pubTime":"2025-05-10 00:34","pubTimestamp":1746808440,"startTime":"0","endTime":"0","summary":"在当前市场环境下，券商正通过重仓买入医药板块相关标的、加大对医药行业的研究分析力度以及扩大在医药领域的投资规模等举措，全方位、多层次地深化与医药板块的关联。在持仓变化方面，一季度券商对于医药板块的持仓调整动作频繁，新进持有10只个股，增持3只个股，减持11只个股。今年以来，券商积极调研医药板块相关公司，紧密关注该领域发展动态。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2025-05-10/doc-inevyxcn3939697.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-05-10/doc-inevyxcn3939697.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1515","BK1161","09939","159938","BK1574"],"gpt_icon":0},{"id":"2534332874","title":"中國駐智利大使館：比亞迪和青山未公司停止投資 願與當地政府對話","url":"https://stock-news.laohu8.com/highlight/detail?id=2534332874","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534332874?lang=zh_tw&edition=fundamental","pubTime":"2025-05-09 22:17","pubTimestamp":1746800240,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["SG9999002828.SGD","LU0979878070.USD","EVS.SI","LU0211977185.USD","LU0269904917.USD","BK1515","HYDD.SI","LU1961090484.USD","LU0823038988.USD","LU0540923850.HKD","LU1813983027.USD","01211","LU0683595622.HKD","LU0175139822.USD","LU1328277881.USD","LU0588546209.SGD","LU0244354667.USD","LU0633140560.USD","LU0823414551.USD","LU1880383440.USD","LU2039709279.SGD","00285","LU1781817850.SGD","BK1594","LU0348767384.USD","SG9999014674.SGD","LU1861214812.USD","LU1794554557.SGD","LU2289578879.USD","LU0531971595.HKD","LU0039217434.USD","LU0819123356.HKD","BYDDY","LU0561508036.HKD","LU1580142542.USD","LU1868837565.USD","IE00BD6J9T35.USD","81211","LU0348827113.USD","LU2148510915.USD","LU1064131003.USD","LU1720050803.USD","LU0327786744.USD","LU2663582299.SGD","LU0531970944.HKD","BK0169","LU1303224171.USD","002594","LU0359202008.SGD","LU0516422366.SGD"],"gpt_icon":0},{"id":"2534100774","title":"石藥集團1類新藥SYH2046獲FDA批准開展臨牀試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=2534100774","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534100774?lang=zh_tw&edition=fundamental","pubTime":"2025-05-09 19:01","pubTimestamp":1746788515,"startTime":"0","endTime":"0","summary":"5月9日，石药集团发布公告，宣布其开发的化药1类新药SYH2046片已获得美国食品药品监督管理局批准，可以在美国开展临床试验。该产品也已于2025年4月获得中国国家药品监督管理局的批准，允许在中国进行临床试验。SYH2046片是一款具有完全自主知识产权的全新结构first-in-class小分子药物，主要适应症为急性心肌梗死后心力衰竭。目前，公司已在国内外提交多项该产品的专利申请。文章来源：财中社石药集团1类新药SYH2046获FDA批准开展临床试验","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509191055a6d902d5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509191055a6d902d5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0501845795.SGD","BK1141","LU1226287792.SGD","LU0072913022.USD","BK1583","IE0008368742.USD","BK1191","LU1226288253.USD","IE00BZ08YT58.USD","LU1226287875.USD","LU0067412154.USD","LU1152091754.HKD","LU0326950275.SGD","LU1951186391.HKD","LU1993786604.SGD","LU1960683339.HKD","LU1152091168.USD","LU1226287529.USD","01093","IE00BZ08YS42.EUR","LU1226288170.HKD","IE00BZ08YR35.GBP","03347","LU0880133367.SGD","IE00B5MMRT66.SGD","LU0140636845.USD","LU1807302812.USD","BK1576","SG9999004220.SGD","BK1521","IE00B031HY20.USD","LU1008478684.HKD","IE0008369823.USD","BK1515","IE00B543WZ88.USD"],"gpt_icon":0},{"id":"2534104693","title":"復星醫藥(02196)附屬菌濟健康獲美國 FDA 藥品臨牀試驗批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2534104693","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534104693?lang=zh_tw&edition=fundamental","pubTime":"2025-05-09 18:48","pubTimestamp":1746787704,"startTime":"0","endTime":"0","summary":"智通财经APP讯，复星医药(02196)发布公告，该公司控股子公司上海菌济健康科技有限公司(以下简称“菌济健康”)收到美国 FDA(即美国食品药品监督管理局)关于同意 LBP-ShC4 开展临床试验的批准。菌济健康拟于条件具备后开展 LBP-ShC4 的 I 期临床试验。LBP-ShC4 为集团自主研发的活体生物治疗产品，拟用于治疗雄激素脱发(AGA)。截至 2025 年 4 月，集团现阶段针对 LBP-ShC4 的累计研发投入约为人民币 0.17 亿元(未经审计)。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1291488.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0188","03347","BK0175","BK0060","600196","BK0096","BK0239","BK0187","BK0183","BK0196","BK0028","BK1593","02196","BK1515","BK1583","BK0012","BK1576","BK1141","BK1191"],"gpt_icon":0},{"id":"2534894824","title":"阿里吳泳銘再提創業，將採用“飽和式投入”打法","url":"https://stock-news.laohu8.com/highlight/detail?id=2534894824","media":"虎嗅APP","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534894824?lang=zh_tw&edition=fundamental","pubTime":"2025-05-09 18:47","pubTimestamp":1746787620,"startTime":"0","endTime":"0","summary":"与此同时，吴泳铭提出“饱和式投入”打法。虎嗅独家获悉，吴泳铭所提及的饱和式投入除了围绕AI、云等核心业务的硬件与资源投入外，还包括了对于既有绩效机制、组织流程等维度的改革。吴泳铭内部信的背景是“510阿里日”。今年阿里日和以往的差异是，阿里高层希望集团内的精神面貌有所变化。接下来集团将以饱和式投入的打法，聚焦于几大核心战役。阿里的基因里没有“守成”，只有“创造”。阿里人，回归初心，重新创业。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://mp.weixin.qq.com/s?__biz=MTQzMjE1NjQwMQ==&mid=2656090065&idx=3&sn=6940aef2d3b7d4f1f0e3bad5f9d5ba01&chksm=67ed2897f36cada55889f319cef10b1dec5b2f57d6dce9f4f61b2df4a0bcbfe5f7ba9f17516b&scene=0#rd","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"weixin_highlight","symbols":["BK4535","ALBmain","BK4554","BK4585","BABA","BK1571","LU1769817096.USD","LU0979878070.USD","LU1823568750.SGD","LU1242518857.USD","BK1501","LU1152091168.USD","LU1152091754.HKD","00241","LU1046421795.USD","LU1769817179.HKD","BK1142","LU0348816934.USD","LU0880133367.SGD","BK4533","IE00B0JY6N72.USD","LU0821914370.USD","LU1048588211.SGD","LU1242518931.SGD","IE00BFMHRM44.USD","LU0047713382.USD","09988","LU1282648689.USD","LU0328353924.USD","BK1591","BK4122","LU0918141705.HKD","BK4220","BK1189","BK1247","BK4575","BK4581","LU1235294995.USD","LU0310800965.SGD","BK1515","BK4565","LU0052756011.USD","LU0918141887.USD","BK4505","161022","LU0651947912.USD","LU1688375341.USD","BK1589","BK4503"],"gpt_icon":1},{"id":"2534106973","title":"石藥集團(01093)：SYH2046片獲美國臨牀試驗批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2534106973","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534106973?lang=zh_tw&edition=fundamental","pubTime":"2025-05-09 18:31","pubTimestamp":1746786691,"startTime":"0","endTime":"0","summary":"智通财经APP讯，石药集团 发布公告，集团开发的化药1类新药SYH2046片(该产品)已获得美国食品药品监督管理局批准，可以在美国开展临床试验。该产品是一款具有完全自主知识产权的全新结构first-in-class小分子药物，本次获批的临床试验适应症为急性心肌梗死后心力衰竭。临床前研究表明，该产品可显着改善疾病动物模型的心脏功能并降低心脏不良重构，且具有较高的安全性。目前，本集团已在国内外提交该产品的多项专利申请。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1291470.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE0008368742.USD","BK1576","03347","IE00BZ08YT58.USD","LU1152091168.USD","LU1226287792.SGD","01093","LU0140636845.USD","LU1951186391.HKD","LU1807302812.USD","IE00B5MMRT66.SGD","LU1226287529.USD","BK1515","SG9999004220.SGD","BK1141","LU1226288170.HKD","LU1993786604.SGD","IE00BZ08YS42.EUR","LU0072913022.USD","LU1960683339.HKD","BK1583","LU0880133367.SGD","LU1008478684.HKD","IE00BZ08YR35.GBP","LU1152091754.HKD","BK1191","BK1521","LU1226287875.USD","IE00B543WZ88.USD","LU1226288253.USD","LU0326950275.SGD","IE00B031HY20.USD","IE0008369823.USD","LU0067412154.USD","LU0501845795.SGD"],"gpt_icon":0},{"id":"2534310591","title":"石藥集團：SYH2046片獲美國臨牀試驗批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2534310591","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534310591?lang=zh_tw&edition=fundamental","pubTime":"2025-05-09 18:29","pubTimestamp":1746786595,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["LU1226287529.USD","LU1807302812.USD","01093","BK1515","IE00B543WZ88.USD","LU0326950275.SGD","BK1576","LU1226287792.SGD","BK1191","LU0140636845.USD","LU1008478684.HKD","LU0067412154.USD","LU1226287875.USD","LU1960683339.HKD","IE0008368742.USD","IE00B031HY20.USD","LU1951186391.HKD","LU0880133367.SGD","LU0072913022.USD","LU1226288253.USD","LU1152091754.HKD","IE0008369823.USD","LU1993786604.SGD","03347","IE00BZ08YS42.EUR","LU1152091168.USD","IE00B5MMRT66.SGD","BK1141","IE00BZ08YR35.GBP","LU0501845795.SGD","LU1226288170.HKD","SG9999004220.SGD","BK1521","IE00BZ08YT58.USD","BK1583"],"gpt_icon":0},{"id":"2534106420","title":"即時零售大戰前傳：互聯網健康的十年“三國殺”","url":"https://stock-news.laohu8.com/highlight/detail?id=2534106420","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534106420?lang=zh_tw&edition=fundamental","pubTime":"2025-05-09 18:24","pubTimestamp":1746786254,"startTime":"0","endTime":"0","summary":"互要流量","market":"hk","thumbnail":"https://wpimg-wscn.awtmt.com/80a4ddb7-699e-49c8-b5bb-3d8b9af64cea.png","type":0,"news_type":0,"thumbnails":["https://wpimg-wscn.awtmt.com/80a4ddb7-699e-49c8-b5bb-3d8b9af64cea.png"],"rights":{"source":"wallstreetcn_hot_news","url":"https://wallstreetcn.com/articles/3746786","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3746786","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"wallstreetcn_hot_news","symbols":["LU0348827113.USD","LU0231483743.USD","LU1282651121.HKD","METmain","LU0359201885.HKD","LU0819123356.HKD","LU1720051108.HKD","LU2125910500.SGD","06618","LU0463099449.HKD","LU1201861165.SGD","MPNGY","BK1515","HBBD.SI","LU0128525689.USD","03690","LU2257852520.SGD","LU0140636845.USD","LU0531971595.HKD","HMTD.SI","LU1808992512.USD","89988","LU2097828474.EUR","09939","ALBmain","BK4504","LU0181495838.USD","LU0029875118.USD","00241","LU0890818403.SGD","LU2242644610.SGD","89618","BK4579","LU1328277881.USD","LU0871576103.HKD","LU0700851271.USD","BK4524","LU0651946864.USD","LU0315179316.USD","BK1584","86618","LU1046422090.SGD","LU0594300179.USD","LU1675838814.USD","LU1044876610.USD","BK1583"],"gpt_icon":1},{"id":"2534177980","title":"石藥集團(01093)5月9日註銷2545萬股已回購股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2534177980","media":"智通财经","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534177980?lang=zh_tw&edition=fundamental","pubTime":"2025-05-09 17:57","pubTimestamp":1746784654,"startTime":"0","endTime":"0","summary":"智通财经APP讯，石药集团(01093)发布公告，于2025年5月9日注销2545万股已回购股份。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1291434.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1993786604.SGD","LU1226288253.USD","LU1152091754.HKD","LU1951186391.HKD","LU0880133367.SGD","BK1515","IE00BZ08YS42.EUR","LU0072913022.USD","LU0067412154.USD","LU1807302812.USD","LU1152091168.USD","LU0501845795.SGD","IE00B543WZ88.USD","IE00B031HY20.USD","LU1226287875.USD","LU1226288170.HKD","IE00BZ08YT58.USD","01093","LU0140636845.USD","SG9999004220.SGD","LU0326950275.SGD","LU1226287529.USD","LU1226287792.SGD","LU1960683339.HKD","BK1521","BK1191","IE00BZ08YR35.GBP","IE0008369823.USD","IE0008368742.USD","IE00B5MMRT66.SGD","LU1008478684.HKD"],"gpt_icon":0},{"id":"2534317293","title":"爭奪水光針200億市場 華熙生物接連獲批2款合規產品 四環醫藥、樂普醫療加入混戰","url":"https://stock-news.laohu8.com/highlight/detail?id=2534317293","media":"时代财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534317293?lang=zh_tw&edition=fundamental","pubTime":"2025-05-09 17:38","pubTimestamp":1746783517,"startTime":"0","endTime":"0","summary":"近半个月以来，国内已有三款水光针产品获批，且均获得国家药监局三类医疗器械认证。4月末，华熙生物（688363.SH）旗下“润百颜·玻玻”、“润致·缇透”两款水光针产品接连获批。据华熙生物方面所述，润百颜·玻玻为其自主研发的含利多卡因水光针，系国内首个获批“面部肤质改善适应症”的水光产品。润致·缇透则为国内首款以“面部肤质改善”为适应症的合规动能素产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202505093400685069.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["00460","BK1191","BK1600","BK1593","BK1515"],"gpt_icon":0},{"id":"2534991171","title":"“太平洋醫藥”君實生物公司點評：拓益收入同比增長 46%，關注 DKK1 胃腸道腫瘤早期數據","url":"https://stock-news.laohu8.com/highlight/detail?id=2534991171","media":"新浪财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534991171?lang=zh_tw&edition=fundamental","pubTime":"2025-05-09 17:22","pubTimestamp":1746782527,"startTime":"0","endTime":"0","summary":"拓益销售收入保持高增速，公司运营效率显著提升，在手现金 30 亿元。2025 年第一季度公司实现收入 5 亿元， 其中，核心产品特瑞普利单抗于国内市场实现销售收入 4.47 亿元。研发费用 3.51 亿元，同比增加 26.89%；管理费用 0.97 亿元，同比减少 21.32%。拓益国内获批 12 项适应症，国际化布局进展顺利。截止目前，拓益已于国内获批 12 项适应症，10 项适应症纳入国家医保目录，其中 4 项为医保独家适应症。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050917245897544f69&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050917245897544f69&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","09939","BK1583","01877","BK1515","BK1161"],"gpt_icon":0},{"id":"2534173533","title":"復星醫藥子公司獲美國FDA批准開展AGA治療臨牀試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=2534173533","media":"财中社","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534173533?lang=zh_tw&edition=fundamental","pubTime":"2025-05-09 16:37","pubTimestamp":1746779855,"startTime":"0","endTime":"0","summary":"5月9日，复星医药发布公告，控股子公司菌济健康获得美国FDA关于LBP-ShC4开展临床试验的批准。公告指出，目前全球尚无用于治疗雄激素脱发的活体生物治疗产品获批上市。尽管获得临床试验批准，但药品研发存在风险，后续的临床研究仍需获得美国药品审评部门的审批，且临床试验可能因安全性和有效性问题而终止。2025年一季度，复星医药实现收入94.20亿元，归母净利润7.65亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509164519a477e291&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509164519a477e291&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1576","BK1583","02196","BK1593","03347","BK1141","BK1515"],"gpt_icon":0}],"pageSize":20,"totalPage":18,"pageCount":3,"totalSize":342,"code":"91000000","status":"200"}]}}